NKID,COB, CAMP, ESPD, CANI, OPTC (pulled back), RDCM, TTIL, LATD, MXTR, GO, INIT, MCAF, IFCI, INPH, BWEB, EXAR, TEK, .. to name a few just this first 6 trading sessions of March. Others were good for 1-2 sessions only like HHGP, PCLN, CMGI, etc.The difficult thing to do in these markets is getting stocks that are still under $100 a share and possibly even under $50 and $25. I saw NSOL and wow, I once said it would be 500 a share but I was half joking. I could not afford to make enough trading stocks over $200 and buy the amount I like to buy. Does anyone remember little MYGN from February seventh? It triggered on February 4th at 80 and today it closed at 229 7/8. I had it for weeks but not this long. That' just amazing, but now MYGN is just not a good trade. Remember PCOP at about 30 round the same time today traded as high as 104. The challenge is to get new ones and watch them run up. The 'most active' is replete with stocks over $200 and although that is great for portfolios that own them, but not very practical for traders especially if you can only afford 100-200 shares. We'll do it because the nature of this market is for the 'new economy' to move over and take over for the older stocks.. Earnings season next month should reveal a whole slew of new ones. CAMP still looking good and maybe LATD will move up even more. The fun is in finding out.
The next challenge is knowing how to wait for some of our biotechs to come back without chasing them. ABSC was lucky, CEGE was lucky yesterday, not so hot today. Others are still correcting, some look ripe others still are overripe. |
